One year on from introducing the AQS3TMpro, a powerful new protein characterization solution, we demonstrated compelling new application data and significant endorsements from leading biopharmaceutical … Read more “Inspiring innovative biotherapeutic protein drug development at PEGS 2019”
Our team recently joined international bioprocess professionals at the Bioprocessing Summit, where we discussed practical solutions for bioprocess challenges. Karan Shah, Principal Development Associate, Analytical … Read more “Immunogen presents MMS data in talk at Bioprocessing Summit”
We have just returned from the Biotherapeutics Analytical Summit in Virginia. What a great celebration of the conference’s 10th birthday! We were inundated with fascinating … Read more “The Hot Topic of Biotherapeutics Analytical Summit”
PepTalk: The Protein Science Week is one of the largest annual gatherings of protein science researchers in the world. The RedShiftBio team attended in January … Read more “Celebrating new analytical techniques to accelerate the development of life saving biotherapeutics at PepTalk”
The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal … Read more “AQS3pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019”
BPS18 was the 62nd annual meeting for the Biophysical Society, one of the largest gathering of biophysicists in the world. There were more than 7,000 … Read more “Biophysical Society: educating biophysicists on cutting edge technologies in protein characterization”
RedShift™, RedShiftBio®, See Change®, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.